13F Pro Quality Score
Below size threshold
Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $19.7M in revenue and is scored on the micro-cap board instead.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
Reported revenue, net income and operating margin by fiscal year, from WORK Medical Technology Group LTD's annual filings on SEC EDGAR.
| Period | Form | Revenue | Net income | Op. marginOperating margin |
|---|---|---|---|---|
| FY 2025 | 20-F | $9.8M | $-1.1M | -11.0% |
| FY 2024 | 20-F | $11.5M | $-3.5M | -31.9% |
| FY 2023 | 20-F | $13.6M | $112.0K | 0.8% |
| FY 2022 | 20-F | $19.7M | $865.2K | 5.7% |
Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.
WORK Medical Technology Group LTD (WOK) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. WOK is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $19.7m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (FY 2025), WORK Medical Technology Group LTD reports quarterly revenue of $9.8M, net income of $-1.1M, an operating margin of -11.0%. WOK trades on the Nasdaq exchange and files with the SEC under CIK 1929783. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate WOK daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for WORK Medical Technology Group LTD directly from SEC EDGAR.